203 related articles for article (PubMed ID: 31322068)
1. Changes in the Expression Profile of VEGF-A, VEGF-B, VEGFR-1, VEGFR-2 in Different Grades of Endometrial Cancer.
Dziobek K; Opławski M; Grabarek BO; Zmarzły N; Tomala B; Halski T; Leśniak E; Januszyk K; Brus R; Kiełbasiński R; Boroń D
Curr Pharm Biotechnol; 2019; 20(11):955-963. PubMed ID: 31322068
[TBL] [Abstract][Full Text] [Related]
2. Expression Profile of VEGF-C, VEGF-D, and VEGFR-3 in Different Grades of Endometrial Cancer.
Oplawski M; Dziobek K; Zmarzły N; Grabarek B; Halski T; Januszyk P; Kuś-Kierach A; Adwent I; Dąbruś D; Kiełbasiński K; Boroń D
Curr Pharm Biotechnol; 2019; 20(12):1004-1010. PubMed ID: 31333122
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of VEGF and its receptors in endometrioid endometrial cancer.
Dobrzycka B; Terlikowski SJ; Kwiatkowski M; Garbowicz M; Kinalski M; Chyczewski L
Ginekol Pol; 2010 Jun; 81(6):422-5. PubMed ID: 20695190
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of VEGF ligands and receptors in prostate cancer.
Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
[TBL] [Abstract][Full Text] [Related]
5. Glutamate Neonatal Excitotoxicity Modifies VEGF-A, VEGF-B, VEGFR-1 and VEGFR-2 Protein Expression Profiles During Postnatal Development of the Cerebral Cortex and Hippocampus of Male Rats.
Castañeda-Cabral JL; Beas-Zarate C; Gudiño-Cabrera G; Ureña-Guerrero ME
J Mol Neurosci; 2017 Sep; 63(1):17-27. PubMed ID: 28755050
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of immunohistochemical expression of the angiogenic molecules vascular endothelial growth factor-A, vascular endothelial growth factor receptor-1 and vascular endothelial growth factor receptor-2 in patients with classical Hodgkin lymphoma.
Dimtsas GS; Georgiadi EC; Karakitsos P; Vassilakopoulos TP; Thymara I; Korkolopoulou P; Patsouris E; Kittas C; Doussis-Anagnostopoulou IA
Leuk Lymphoma; 2014 Mar; 55(3):558-64. PubMed ID: 23772669
[TBL] [Abstract][Full Text] [Related]
7. Expression of Semaphorin 3B (SEMA3B) in Various Grades of Endometrial Cancer.
Dziobek K; Opławski M; Grabarek B; Zmarzły N; Januszyk P; Adwent I; Dąbruś D; Leśniak E; Kiełbasiński R; Kieszkowski P; Boroń D
Med Sci Monit; 2019 Jun; 25():4569-4574. PubMed ID: 31217417
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic significance of vascular endothelial growth factor-A (VEGF-A) and its receptor in canine prostate cancer.
Leis-Filho AF; Lainetti PD; Kobayashi PE; Palmieri C; Amorim RL; Fonseca-Alves CE
Prostate; 2021 Oct; 81(14):1021-1031. PubMed ID: 34320239
[TBL] [Abstract][Full Text] [Related]
9. [Expression of vascular endothelial growth factor and its receptors in endometrial carcinoma].
Wang H; Chen G; Zhang B
Zhonghua Bing Li Xue Za Zhi; 2002 Oct; 31(5):391-5. PubMed ID: 12485477
[TBL] [Abstract][Full Text] [Related]
10. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
11. The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.
Anisimov A; Leppänen VM; Tvorogov D; Zarkada G; Jeltsch M; Holopainen T; Kaijalainen S; Alitalo K
Sci Signal; 2013 Jul; 6(282):ra52. PubMed ID: 23821770
[TBL] [Abstract][Full Text] [Related]
12. A cyclic peptide reproducing the α1 helix of VEGF-B binds to VEGFR-1 and VEGFR-2 and inhibits angiogenesis and tumor growth.
Assareh E; Mehrnejad F; Mansouri K; Esmaeili Rastaghi AR; Naderi-Manesh H; Asghari SM
Biochem J; 2019 Feb; 476(4):645-663. PubMed ID: 30700502
[TBL] [Abstract][Full Text] [Related]
13. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Changes in the Expression Pattern of EDIL3 in Different Grades of Endometrial Cancer.
Oplawski M; Dziobek K; Zmarzły N; Grabarek B; Tomala B; Leśniak E; Adwent I; Januszyk P; Dąbruś D; Boroń D
Curr Pharm Biotechnol; 2019; 20(6):483-488. PubMed ID: 30961491
[TBL] [Abstract][Full Text] [Related]
15. Expression of vasohibin as a novel endothelium-derived angiogenesis inhibitor in endometrial cancer.
Yoshinaga K; Ito K; Moriya T; Nagase S; Takano T; Niikura H; Yaegashi N; Sato Y
Cancer Sci; 2008 May; 99(5):914-9. PubMed ID: 18325046
[TBL] [Abstract][Full Text] [Related]
16. Xiaotan Sanjie decoction inhibits angiogenesis in gastric cancer through Interleukin-8-linked regulation of the vascular endothelial growth factor pathway.
Shi J; Lu Y; Wei P
J Ethnopharmacol; 2016 Aug; 189():230-7. PubMed ID: 27224240
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors.
Färkkilä A; Anttonen M; Pociuviene J; Leminen A; Butzow R; Heikinheimo M; Unkila-Kallio L
Eur J Endocrinol; 2011 Jan; 164(1):115-22. PubMed ID: 21041381
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Variances in VEGF-A-D and VEGFR-1-3 Expression in the Ishikawa Endometrial Cancer Cell Line Treated with Salinomycin and Anti-Angiogenic/Lymphangiogenic Effect.
Kras P; Talkowski K; Grabarek BO; Skalska-Dziobek N; Boroń D; Oplawski M
Curr Pharm Biotechnol; 2021; 22(5):697-705. PubMed ID: 32648839
[TBL] [Abstract][Full Text] [Related]
19. Cellular distribution of vascular endothelial growth factor A (VEGFA) and B (VEGFB) and VEGF receptors 1 and 2 in focal cortical dysplasia type IIB.
Boer K; Troost D; Spliet WG; van Rijen PC; Gorter JA; Aronica E
Acta Neuropathol; 2008 Jun; 115(6):683-96. PubMed ID: 18317782
[TBL] [Abstract][Full Text] [Related]
20. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
